Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Powderly

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
AIDS Research and Human Retroviruses|April 10, 1997
Molecular epidemiology of mucosal candidiasis in HIV-positive womenK M Dahl, E J Keath, V J Fraser, et al.
AIDS (London, England)|April 24, 2001
Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapyP Tebas, K Henry, R Nease, et al.
Irish Medical Journal|February 1, 1984
Hypothalamic-pituitary-adrenal function in patients receiving intermittent high dose prednisone therapy for lymphomaP Warde, W G Powderly, J J Fennelly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapyW Tantisiriwat, P Tebas, D B Clifford, et al.
AIDS Clinical Care|September 8, 2001
HIV expertise: a roundtableS L Boswell, F M Hecht, W G Powderly, et al.
AIDS Research and Human Retroviruses|December 1, 1993
Alterations in spliced and unspliced HIV-1-specific RNA detection in peripheral blood mononuclear cells of individuals with varying CD4-positive lymphocyte countsM Arens, T Joseph, S Nag, et al.
Lancet (London, England)|March 7, 2003
An objective case definition of lipodystrophy in HIV-infected adults: a case-control studyA Carr, S Emery, M Law, et al.
HIV Medicine|August 24, 2006
Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapyS Sungkanuparph, R K Groger, E T Overton, et al.
AIDS (London, England)|October 8, 1999
Predictors of optimal virological response to potent antiretroviral therapyW G Powderly, M S Saag, S Chapman, et al.
Retina (Philadelphia, Pa.)|January 1, 1997
Major blinding complication of acquired immune deficiency syndrome (AIDS)L Akduman, J R Arribas, L V Del Priore, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
AIDS Research and Human Retroviruses|April 10, 1997
Molecular epidemiology of mucosal candidiasis in HIV-positive womenK M Dahl, E J Keath, V J Fraser, et al.
AIDS (London, England)|April 24, 2001
Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapyP Tebas, K Henry, R Nease, et al.
Irish Medical Journal|February 1, 1984
Hypothalamic-pituitary-adrenal function in patients receiving intermittent high dose prednisone therapy for lymphomaP Warde, W G Powderly, J J Fennelly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapyW Tantisiriwat, P Tebas, D B Clifford, et al.
AIDS Clinical Care|September 8, 2001
HIV expertise: a roundtableS L Boswell, F M Hecht, W G Powderly, et al.
AIDS Research and Human Retroviruses|December 1, 1993
Alterations in spliced and unspliced HIV-1-specific RNA detection in peripheral blood mononuclear cells of individuals with varying CD4-positive lymphocyte countsM Arens, T Joseph, S Nag, et al.
Lancet (London, England)|March 7, 2003
An objective case definition of lipodystrophy in HIV-infected adults: a case-control studyA Carr, S Emery, M Law, et al.
HIV Medicine|August 24, 2006
Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapyS Sungkanuparph, R K Groger, E T Overton, et al.
AIDS (London, England)|October 8, 1999
Predictors of optimal virological response to potent antiretroviral therapyW G Powderly, M S Saag, S Chapman, et al.
Retina (Philadelphia, Pa.)|January 1, 1997
Major blinding complication of acquired immune deficiency syndrome (AIDS)L Akduman, J R Arribas, L V Del Priore, et al.
Pageof 13